Home › Idiopathic Thrombocytopenic Purpura › Ohio › Cleveland
Idiopathic Thrombocytopenic Purpura clinical trials in Cleveland, OH
3 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Cleveland Clinic, Cleveland
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Cleveland Clinic, Cleveland
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
RecruitingPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Greenville, NC6 studies
- Washington, DC6 studies
- Boston, MA6 studies
- The Bronx, NY5 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Houston, TX4 studies
- Portland, OR4 studies
- New Orleans, LA3 studies
- New Haven, CT3 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer43 studies
- Cancer (all types)36 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Ovarian Cancer30 studies
- Metastatic Cancer30 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer20 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.